Segmental wall motion abnormalities in idiopathic dilated cardiomyopathy and their effect on prognosis

Laurent Fauchier1, Veronique Eder, Danielle Casset-Senon

  • 1Services de Service de Cardiologie B, Centre Hospitalier Universitaire Trousseau, Tours, France. lfau@med.univ-tours.fr

Insights

Segmental wall motion abnormalities in idiopathic dilated cardiomyopathy (IDC) are common and linked to worse outcomes. Localized abnormalities and interventricular dyssynchrony predict cardiac events and heart transplantation.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Cardiac Imaging

Background:

  • Idiopathic dilated cardiomyopathy (IDC) exhibits significant variability in segmental wall motion abnormalities and patient prognosis.
  • Accurate assessment of cardiac function and dyssynchrony is crucial for predicting outcomes in IDC patients.

Purpose of the Study:

  • To investigate the relationship between segmental wall motion abnormalities, interventricular dyssynchrony, and prognosis in patients with idiopathic dilated cardiomyopathy.
  • To identify predictors of cardiac death or heart transplantation in IDC.

Main Methods:

  • Radionuclide ventriculography with Fourier analysis was employed in 107 patients with IDC.
  • Amplitude analysis identified wall motion abnormalities, while phase analysis assessed interventricular and intraventricular dyssynchrony.

Main Results:

  • Global hypokinesis was observed in 52% of patients, with localized abnormalities in 48%.
  • Localized wall motion abnormalities correlated with larger left ventricular end-diastolic diameters and lower ejection fractions.
  • Increased standard deviation of the left ventricular phase, reduced right ventricular ejection fraction, and localized wall motion abnormalities independently predicted adverse cardiac events.

Conclusions:

  • Segmental wall motion abnormalities are prevalent in IDC and associated with severe systolic dysfunction.
  • These abnormalities, along with specific measures of dyssynchrony and ventricular function, are significant prognostic indicators in IDC.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...